Flowflex News & Product Updates

Stay up to date with Flowflex news, counterfeit notices, and product updates for COVID-19 and Flu A/B home tests.

Flowflex Launches First FDA-Cleared 4-in-1 Home Test Detecting RSV, Flu A/B and COVID for Ages 6 Months+

SAN DIEGO, CA., January 22, 2026 — ACON Laboratories, Inc. today announced the retail availability of the first FDA-cleared home test which allows families to identify four major respiratory infections, including Respiratory Syncytial Virus (RSV), in adults and children as young as 6 months using a single test. The Flowflex® Plus RSV + Flu A/B + COVID 4-in-1 test empowers consumers to quickly identify the cause of symptoms such as fever, cough, congestion, and wheezing. The ability to test infants for RSV is especially significant because RSV is the leading cause of hospitalization in young children, as referenced by the U.S. Centers for Disease Control and Prevention (CDC). For parents and caregivers, the ability to distinguish between RSV, Flu, and

Read More »

ACON Laboratories Announces Breakthrough 4-in-1 Flowflex® Plus RSV + Flu A/B + COVID Home Test

SAN DIEGO, CA, October 27, 2025 – ACON Laboratories, Inc., a leading global medical device manufacturer, announced today that its Flowflex® Plus RSV + Flu A/B + COVID Home Test has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). The Flowflex Plus RSV + Flu A/B + COVID Home Test (K251749) is an over-the-counter (OTC) rapid antigen test that can be administered in the comfort and privacy of consumers’ homes. This new test will be manufactured domestically in ACON’s state-of-the-art facility in San Diego, CA.  The Flowflex Plus RSV + Flu A/B + COVID Home Test is a lateral flow immunoassay intended for the rapid, simultaneous qualitative detection and differentiation of respiratory syncytial virus (RSV), influenza A, influenza B (Flu A/B), and

Read More »

Flowflex Plus COVID-19 and Flu A/B Home Test New Shelf-life Extension

Since the launch of its Flowflex Plus COVID-19 and Flu A/B Home Test, ACON Laboratories, Inc. has continued testing for product stability to extend the shelf-life. These results have been shared with the FDA. We are pleased to announce that the request to extend the Flowflex Plus COVID-19 and Flu A/B Home Test shelf-life from 15 months to 24 months, when stored at 36-86°F (2-30°C), has been granted. The Flowflex Plus COVID-19 and Flu A/B Home Test has an expiration date that is extended by 9 months. Look up the new expiration date using the lot number printed on the test kit box. Future shelf-life expiration date extensions will be communicated as they become available. If you have questions, please

Read More »

Flowflex® Plus COVID-19 + Flu A/B Home Test Receives FDA 510(k) Clearance

SAN DIEGO, CA., May 12, 2025 – ACON Laboratories, Inc., a leading global medical device manufacturer, announced today that its Flowflex® Plus COVID-19 + Flu A/B Home Test has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). The Flowflex Plus COVID-19 + Flu A/B Home Test (K250377) is an over-the-counter (OTC) rapid antigen test that can be administered in the comfort and privacy of consumers’ homes. This version of the test will continue to be manufactured domestically in ACON’s state-of-the-art San Diego, CA facility. The Flowflex Plus COVID-19 and Flu A/B Home Test received Emergency Use Authorization (EUA) in July 2024, as a lateral flow immunoassay intended for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B protein antigens.

Read More »

Public Notice Of Counterfeit Flowflex® COVID-19 Test Kits

ACON Laboratories, Inc. has become aware of counterfeit Flowflex COVID-19 Antigen Home Test kits displaying Lot number COV3090017 which are being illegally sold in the United States and Puerto Rico by unauthorized distributors. Although these counterfeit test kits appear to display an authentic Flowflex COVID-19 Antigen Home Test Lot number, these counterfeit test kits were not manufactured, imported, or distributed by ACON Laboratories. Counterfeit test kits displaying Lot number COV3090017 may be distinguished by examining the front of the kit box. On the counterfeit COV3090017 kit boxes, the sides of the illustrated tube do not extend into the teal. On authentic kit boxes, the sides of the illustrated tube extend into the teal and stop at the edge of the

Read More »

Public Notice Of Counterfeit Flowflex® COVID-19 Test Kits

ACON Laboratories, Inc. has become aware of counterfeit Flowflex COVID-19 Antigen Home Test kits displaying Lot number COV3090005 which are being illegally sold in the United States and Puerto Rico by unauthorized distributors. Although these counterfeit test kits appear to display an authentic Flowflex COVID-19 Antigen Home Test Lot number, these counterfeit test kits were not manufactured, imported, or distributed by ACON Laboratories. Counterfeit tests that display Lot number COV3090005 often produce invalid results (no Control line). The performance of these counterfeit tests has not been established and there is concern about the risk of inaccurate results when people use these unauthorized tests. Additionally, the 2D-datamatrix printed on the counterfeit test cassettes has been found to scan for invalid Lot

Read More »

Public Notice Of Counterfeit Flowflex® COVID-19 Test Kits

ACON Laboratories, Inc. has become aware of counterfeit Flowflex COVID-19 Antigen Home Test kits displaying Lot number COV3060007 which are being illegally sold in the United States by unauthorized distributors. Although these counterfeit test kits appear to display an authentic Flowflex COVID-19 Antigen Home Test Lot number, these counterfeit test kits were not manufactured, imported, or distributed by ACON Laboratories. These counterfeit test kits may be identified by mismatched Lot numbers on the test kit box label and test cassette pouch. These counterfeit test cassettes display a different Lot number on the test cassette pouch than the Lot number COV3060007 printed on the kit box label sticker on the outside of the test kit box. Additionally, these counterfeit test cassettes

Read More »

Flowflex® Plus COVID-19 and Flu A/B Home Test Receives FDA EUA

SAN DIEGO, CA., July 29, 2024 – ACON Laboratories, Inc., a leading global medical device manufacturer for 25 years, announced today that its Flowflex® Plus COVID-19 and Flu A/B Home Test has been authorized for emergency use by the U.S. Food and Drug Administration. The new Flowflex Plus COVID-19 and Flu A/B Home Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B protein antigens. This test is authorized for non-prescription home use with self-collected anterior nares nasal swab specimens from individuals aged 14 years or older, or with adult-collected anterior nasal swab specimens from individuals two (2) years or older. This test is only authorized for individuals with signs

Read More »

Statement On The Omicron BA.2.86 And JN.1 Variants

ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants. According to the Centers for Disease Control and Prevention (CDC) COVID Data Tracker, the Omicron variant remains the dominant variant circulating in the United States. Among the new Omicron variants, BA.2.86 and JN.1 are currently the fastest-growing variants in the United States. Based on the study results from testing live clinical samples or virus samples of variants, the Flowflex® COVID-19 Antigen Home Test can reliably detect the Omicron B.1.1.529, BA.1, BA.2, BA.2.12.1, BA.2.3, BA.2.75.5, XBB, BA.4, BA.4.6, BA.5, BA.5.5, BQ.1, BQ.1.1, BQ.1.3, BQ.1.16, BF.5 and BF.7 variants with various nucleocapsid protein mutations, including many defining mutations for the Omicron variants. Therefore, our test has demonstrated adequate sensitivity against

Read More »

ACON Receives FDA 510(k) Clearance for Flowflex® COVID-19 Test; Will be Manufactured in San Diego

SAN DIEGO, CA, November 9, 2023 – ACON Laboratories, Inc. is proud to announce that the U.S. Food & Drug Administration (FDA) has granted 510(k) marketing clearance for the Flowflex® COVID-19 Antigen Home Test. This is the first FDA 510(k) for an over-the-counter (OTC) rapid antigen test for SARS-CoV-2, the virus which causes COVID-19. The 510(k) version of the Flowflex COVID-19 Antigen Home Test will also be produced domestically, in ACON Laboratories’ new 97,000 square foot San Diego manufacturing facility. The 510(k) cleared Flowflex COVID-19 Antigen Home Test is indicated for use only by symptomatic individuals within the first six days after symptom onset. An initial negative result must be followed by retesting between 48 and 72 hours after the

Read More »
Back To Top